| __timestamp | MiMedx Group, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 90480000 | 4042025 |
| Thursday, January 1, 2015 | 133384000 | 5279557 |
| Friday, January 1, 2016 | 179997000 | 8073913 |
| Sunday, January 1, 2017 | 220119000 | 44864073 |
| Monday, January 1, 2018 | 258528000 | 53488904 |
| Tuesday, January 1, 2019 | 198205000 | 65896361 |
| Wednesday, January 1, 2020 | 181022000 | 69968267 |
| Friday, January 1, 2021 | 198359000 | 92047281 |
| Saturday, January 1, 2022 | 208789000 | 131819000 |
| Sunday, January 1, 2023 | 211124000 | 87501000 |
In pursuit of knowledge
In the competitive landscape of the pharmaceutical and biotech industries, understanding the financial strategies of companies is crucial. This analysis focuses on the Selling, General, and Administrative (SG&A) expenses of Pharming Group N.V. and MiMedx Group, Inc. from 2014 to 2023.
MiMedx Group, Inc. has shown a consistent increase in SG&A expenses, peaking in 2018 with a 186% rise from 2014. This trend reflects their aggressive market expansion and investment in administrative capabilities.
Pharming Group N.V., on the other hand, experienced a dramatic 3,160% increase in SG&A expenses over the same period, with a notable surge in 2022. This indicates a strategic shift towards scaling operations and enhancing market presence.
These trends highlight the differing strategies of these companies in managing operational costs and expanding their market footprint.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Pharming Group N.V.
Genmab A/S and Pharming Group N.V.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Pharming Group N.V. vs Apellis Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Amneal Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and MiMedx Group, Inc.
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs MiMedx Group, Inc.
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MiMedx Group, Inc.
Who Optimizes SG&A Costs Better? Bausch Health Companies Inc. or MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing HUTCHMED (China) Limited and MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and MiMedx Group, Inc.
Comparing SG&A Expenses: Soleno Therapeutics, Inc. vs MiMedx Group, Inc. Trends and Insights